Allelotype analysis of intrahepatic cholangiocarcinoma

被引:20
作者
Kang, YK
Kim, YI
Kim, WH
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Chongno Gu, Seoul 110799, South Korea
[2] Inje Univ, Seoul Paik Hosp, Dept Pathol, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Inst Canc Res, Chongno Gu, Seoul 110799, South Korea
关键词
allelotype analysis; cholangiocarcinoma; fractional allelic loss; loss of heterozygosity; microsatellite; tumor suppressor genes;
D O I
10.1038/modpathol.3880108
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To identify the chromosomal loci of allelic loss in intrahepatic cholangiocarcinoma (ICC), we performed an allelotype study of 36 ICCs using 55 genome-wide microsatellite markers. Loss of heterozygosity was found most frequently on 8p (65.6%), 17p (64.7%), and 9p (64.5%), followed by 18q (54.2%), Ip (48.5%), 3p (44.8%), 9q (42.1%), 14q (41.7%), 6q (41.7%), and 1q (40.6%). The fractional allelic loss (FAL) values ranged from 0 to 0.731 (mean, 0.322). Analysis of the relationship between FAL values and clinicopathologic parameters disclosed significantly higher FAL values in moderately to poorly differentiated ICCs than in well-differentiated ones (P < .05), In summary, this study defined for the first time the overall number of chromosomes having allelic loss and the chromosomal arms and/or regions potentially involved in the development of ICC.
引用
收藏
页码:627 / 631
页数:5
相关论文
共 28 条
[1]  
Anbazhagan R, 1998, AM J PATHOL, V152, P815
[2]  
[Anonymous], 1990, ANN SURG, V211, P277
[3]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[4]  
BOVA GS, 1993, CANCER RES, V53, P3869
[5]   Fractional allelic loss in gastric carcinoma correlates with growth patterns [J].
Choi, SW ;
Park, SW ;
Lee, KY ;
Kim, KM ;
Chung, YJ ;
Rhyu, MG .
ONCOGENE, 1998, 17 (20) :2655-2659
[6]   LOSS OF CONSTITUTIONAL HETEROZYGOSITY ON CHROMOSOME-5 AND CHROMOSOME-17 IN CHOLANGIOCARCINOMA [J].
DING, SF ;
DELHANTY, JDA ;
BOWLES, L ;
DOOLEY, JS ;
WOOD, CB ;
HABIB, NA .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1007-1010
[7]   Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites [J].
Dolan, K ;
Garde, J ;
Gosney, J ;
Sissons, M ;
Wright, T ;
Kingsnorth, AN ;
Walker, SJ ;
Sutton, R ;
Meltzer, SJ ;
Field, JK .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :950-957
[8]  
Kang YK, 1999, LAB INVEST, V79, P477
[9]   MUTATIONS OF THE P53 TUMOR-SUPPRESSOR GENE AND THE RAS GENE FAMILY IN INTRAHEPATIC CHOLANGIOCELLULAR CARCINOMAS IN JAPAN AND THAILAND [J].
KIBA, T ;
TSUDA, H ;
PAIROJKUL, C ;
INOUE, S ;
SUGIMURA, T ;
HIROHASHI, S .
MOLECULAR CARCINOGENESIS, 1993, 8 (04) :312-318
[10]  
KIM CJ, 1995, LAB INVEST, V72, P232